SourceBloomberg Technology•Stalecollected in 32m
Insilico Partners to Build AI Longevity Model
AI-driven drug discovery is a high-growth field; see how Insilico is applying it to longevity research.
30-Second TL;DR
What Changed
Insilico Medicine developing AI model for longevity
Why It Matters
This partnership could significantly reduce the time required for identifying longevity-related compounds through generative AI.
What To Do Next
Explore Insilico's open-source tools or publications on AI-driven biology to understand their methodology.
Who should care:Researchers & Academics
Key Points
- •Insilico Medicine developing AI model for longevity
- •Strategic US partnership to accelerate research
- •Focus on AI-driven drug discovery and life extension
Weekly AI Recap
Read this week's curated digest of top AI events →
AI-curated news aggregator. All content rights belong to original publishers.
Original source: Bloomberg Technology ↗
This is a summary, not the original. Read the source, or get the weekly briefing.
The weekly digest
One email a week. Unsubscribe anytime.